Abundant anti-FZD1 antibodies evoked by RFP bound to the transmembrane receptor FZD1 in the ischemic heart tissue, resulting in an inhibition of the endogenous expression of FZD1, which subsequently repressing the Wnt signalling, and thereby supress the cardiac hypertrophy. The gene discussed is NRP1; the disease is cardiac hypertrophy.